We are live on ! Find out more
ITOS

iTeos Therapeutics
ITOS

Delisted

ITOS was delisted on the 28th of August, 2025.

Back to rankings

144 hedge funds and large institutions have $389M invested in iTeos Therapeutics in 2023 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 58 increasing their positions, 48 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

131% more call options, than puts

Call options by funds: $7.51M | Put options by funds: $3.25M

21% more repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 48

1.96% more ownership

Funds ownership: 97.22% → 99.18% (+2%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 15

1% less funds holding

Funds holding: 146 → 144 (-2)

16% less capital invested

Capital invested by funds: $460M → $389M (-$71.9M)

Holders
144
Holders Change
-2
Holders Change %
-1.37%
% of All Funds
2.29%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
15
Increased
58
Reduced
48
Closed
15
Calls
$7.51M
Puts
$3.25M
Net Calls
+$4.26M
Net Calls Change
+$3.9M

Top Buyers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
+$9.25M
2
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$6.4M
3
BlackRock
BlackRock
New York
+$4.74M
4
SVCM
Saturn V Capital Management
Texas
+$4.59M
5
IC
Ikarian Capital
Texas
+$4.43M

Top Sellers

Rank Fund Capital Flow
1
BI
BVF Inc
California
-$7.05M
2
OCA
Octagon Capital Advisors
New York
-$6.32M
3
BC
Boxer Capital
California
-$4.48M
4
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$3.1M
5
Citadel Advisors
Citadel Advisors
Florida
-$2.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$2.87M +$1.09M +85,073 +48%
Prudential Financial
27
Prudential Financial
New Jersey
$2.76M -$503K -39,350 -14%
Charles Schwab
28
Charles Schwab
California
$2.3M +$246K +19,258 +10%
Invesco
29
Invesco
Georgia
$2.27M -$105K -8,202 -4%
BCM
30
Bridgeway Capital Management
Texas
$1.94M +$115K +9,006 +5%
SAM
31
Sectoral Asset Management
Quebec, Canada
$1.7M +$109K +8,499 +6%
Vontobel Holding
32
Vontobel Holding
Switzerland
$1.7M +$109K +8,499 +6%
Principal Financial Group
33
Principal Financial Group
Iowa
$1.67M +$71K +5,555 +4%
BBA
34
Baker Bros. Advisors
New York
$1.65M – – –
PAM
35
Panagora Asset Management
Massachusetts
$1.6M +$323K +25,237 +21%
Fidelity Investments
36
Fidelity Investments
Massachusetts
$1.54M -$691 -54 -0%
Ameriprise
37
Ameriprise
Minnesota
$1.46M -$2.75K -215 -0.2%
D.E. Shaw & Co
38
D.E. Shaw & Co
New York
$1.25M +$447K +34,976 +44%
EF
39
Empowered Funds
Pennsylvania
$1.21M +$115K +9,006 +9%
RAM
40
Readystate Asset Management
Illinois
$1.16M +$221K +17,300 +20%
Los Angeles Capital Management
41
Los Angeles Capital Management
California
$1.16M -$57.1K -4,468 -4%
Bank of America
42
Bank of America
North Carolina
$1.13M -$158K -12,389 -11%
OCA
43
Octagon Capital Advisors
New York
$1.12M -$6.32M -494,000 -83%
Victory Capital Management
44
Victory Capital Management
Texas
$1.09M +$4.49K +351 +0.4%
DCM
45
DAFNA Capital Management
California
$1.08M – – –
AG
46
Algert Global
California
$1.05M +$698K +54,590 +131%
Verition Fund Management
47
Verition Fund Management
Connecticut
$1.04M -$274K -21,459 -18%
Susquehanna International Group
48
Susquehanna International Group
Pennsylvania
$1.02M +$235K +18,345 +25%
Citigroup
49
Citigroup
New York
$945K -$1.9M -148,333 -63%
Rafferty Asset Management
50
Rafferty Asset Management
New York
$933K -$18K -1,409 -2%
1
2
3 4 5

ITOS Hedge Fund Activity: Q3 2023 in Review

144 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in iTeos Therapeutics (ITOS) for Q3 2023, worth a combined $389M — down 16% from $460M a quarter earlier.

Fund positioning in ITOS was balanced in Q3 2023: 15 funds opened new positions, 15 closed out, 58 added to existing stakes and 48 trimmed.

The largest buyer was Deerfield Management, opening a new position worth an estimated $9.25M. The largest seller was BVF Inc, cutting an estimated $7.05M.

  • 144 institutional investors held iTeos Therapeutics (ITOS) as of Q3 2023, down from 146 in Q2 2023.
  • Funds reported $389M of iTeos Therapeutics stock for Q3 2023, down 16% quarter-over-quarter.
  • 15 funds opened new iTeos Therapeutics positions in Q3 2023 and 15 closed out, a net change of 0 holders.
  • The largest iTeos Therapeutics buyer in Q3 2023 was Deerfield Management, an estimated $9.25M added.
  • The largest iTeos Therapeutics seller in Q3 2023 was BVF Inc, an estimated $7.05M sold.

Based on aggregated 13F filings for Q3 2023.